Contemporary management strategies for fibromyalgia.
A roundtable meeting that comprised clinical, patient advocacy, and managed care experts discussed issues regarding the diagnosis and management of fibromyalgia. The panel agreed that earlier diagnosis and treatment, additional education for the medical community, and appropriate management by health plans, including patient access to US Food and Drug Administration-approved fibromyalgia medications, are needed. In addition, physicians, payers, and patient advocates must work to improve clinical, economic, and quality-of-life outcomes for fibromyalgia patients. Finally, treatment and diagnostic guidelines must be updated as advances in disease management are made (including approvals of 3 new pharmacologic agents), and development of a therapeutic category for "fibromyalgia" on payer formularies is needed.
Navarro
Robert P
RP
Navarro Pharma, LLC, 411 Walnut St, #4641, Green Cove Springs, FL 32043, USA. robert.p.navarro@gmail.com
D000700:Analgesics / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D003245:Consensus Statements as Topic; D005356:Fibromyalgia / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D006279:Health Maintenance Organizations; D006801:Humans; D017410:Practice Guidelines as Topic; D012307:Risk Factors
D000700:Analgesics; D000925:Anticoagulants; D000928:Antidepressive Agents